Filter
2148
Text search:
КОВИД-19
Featured
237
5
Language
Document type
628
306
294
244
123
116
115
111
71
53
30
29
24
3
1
Countries / Regions
240
199
183
147
134
124
104
98
91
87
86
82
80
75
73
69
67
50
48
46
44
42
42
39
37
32
30
30
29
28
27
26
25
25
25
24
24
22
22
22
21
21
20
18
18
17
17
16
16
15
15
14
14
14
14
13
12
12
12
12
11
11
11
11
10
10
10
10
10
9
9
9
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
2141
41
25
17
16
14
8
1
Toolboxes
1936
41
24
9
8
8
8
5
5
3
2
2
1
1
1
1
1
1
Strengthening of vaccination interventions during and post-Health Emergency by SARS-CoV-2
General Objective
To strengthen vaccination interventions in the territory, during the COVID-19 health emergency, in order to emergency due to COVID-19, in order to prevent the reintroduction and maintain co
...
Recommendations for the management of oncology patients during the SARS-CoV-2/Covid-19 pandemic
National Directorate for Environment and Health - Guidelines for the prevention of COVID-19 in elderly care workplaces
Guidelines for care of older adults with SARS CoV-2/COVID-19
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
Protocol for the use of rapid tests for the detection of antibodies against SARS - COV-2/COVID-19
The number of COVID-19 cases is on the rise again, with South Africa nearing half of all confirmed cases in the WHO African Region. Threats of new variants loom and low vaccination coverage raises questions on the future of the response to COVID-19. Prevention remains the key strategy in most sub-Sa
...
Le nombre de cas de COVID-19 augmente à nouveau, l’Afrique du Sud comptant pour près de la moitié de tous les cas confirmés de la Région africaine de l’OMS. La menace de nouveaux variants plane, et la faible couverture vaccinale soulève des questions concernant les mesures qui devront êtr
...
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
This document focus on the direct consequences of the virus (morbidity and mortality) in specific populations and on the results of measures aimed at mitigating the spread of the virus, with indirect impacts on socio-economic conditions. In this complex scenario, the gender approach has not received
...
Seit August 2021 empfiehlt die Ständige Impfkommission (STIKO) allen Kindern und Jugendlichen ab 12 Jahren die Corona-Schutzimpfung mit Comirnaty® von BioNTech/Pfizer. Seit Mitte Dezember können auch Kinder zwischen 5 und 11 Jahren mit dem darauf angepassten Impfstoff von BioNTech/Pfizer geimpft
...
The overview of findings from five Latin American countries
síntesis de hallazgos en cinco países de América Latina
SARS-CoV-2 infection and pulmonary tuberculosis: analysis of the situation in Peru
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv
...
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that policies can be tailored to different population groups.
...
Guidance on providing information and psychosocial support to patients hospitalized with COVID-19 infection and their relatives
